Policy | August 03, 2021
API exports surpass imports by value in 2020-21
The govt has rolled out three schemes for promoting the manufacture of API
The govt has rolled out three schemes for promoting the manufacture of API
Drug formulations and biologics make impressive gains
The company is confident of commencing production at both Mahad and Chiplun units soon
Growing R&D budgets of global pharmaceutical companies is the opportunity that Veeda and Bioneeds expect to capitalise on.
The distribution agreement is effective from 1 October 2021 and applies to Bormed products used in pharmaceutical packaging, medical and diagnostic devices
Under the PMBJP, all the districts of the country are covered and ensure easy reach of affordable medicine to the people in every nook and corner of the country
Availability of drugs is being monitored by implementing a three-pronged strategy of supply chain management, demand side management, and affordability.
The additional allocation of Tocilizumab will ensure sufficient availability for COVID-19 patients and augment the government’s efforts to fight the pandemic
The rating withdrawal is based on the company’s request and in line with CRISIL Rating’s policy on withdrawal of ratings.
State governments and UTs have been asked to monitor proper distribution within the state/UT covering government and private hospitals
Subscribe To Our Newsletter & Stay Updated
